Page 82 - SAMRC AnnualReport 2025-26
P. 82

CTR also expanded its One Health research
            agenda  to  address  gaps  in  cross-species  and
            environmental transmission. Projects included
            culture-independent detection of  Mycobacterium
            tuberculosis complex DNA in African buffalo,
            improved detection of pathogenic Mycobacterium
            species in soil and water sediments, and high-
            resolution phylogenetic analyses of M. bovis. These
            initiatives strengthened molecular epidemiology,
            diagnostics, and surveillance within wildlife and
            environmental reservoirs.
            Research in host genetics and genomics
            focused on African genomic diversity and its
            role in TB susceptibility, disease outcomes, and
            pharmacogenomics. Key achievements included
            confirmation  of  HLA-II  associations,  investigation
            of mitochondrial and nuclear genetic determinants,
            characterisation of pharmacogenetic variation
            affecting TB drug metabolism, and development
            of   Africa-specific   genomic   resources.   This
            work addresses longstanding gaps in genomic
            representation and  supports  precision medicine
            and evidence-based public health strategies.

            In  the  clinical  and  translational  research  domain,
            the  Centre  advanced  AI-driven  PET-CT  imaging
            for improved detection and characterisation of
            pulmonary and subclinical TB, evaluated long-
            term  outcomes  of  imaging-defined  TB,  and
            contributed to TB vaccine trials. Diagnostic
            research further assessed targeted next-generation
            sequencing for rapid drug susceptibility testing,
            identifying  emerging  bedaquiline  resistance  and
            informing precision treatment, prevention, and
            outbreak monitoring. Additional studies explored
            immune mechanisms, host-directed therapies,
            nanotherapeutics, and novel antimycobacterial
            agents to combat TB and TB-related lung
            pathology. Collectively, these activities reinforced
            CTR’s contribution to innovative, context-relevant
            TB research with measurable impact on TB control.

            Building Capacity Through
            Training, Mentorship, and Support

            Capacity development remains central to CTR’s
            mission, with initiatives designed to advance equity,
            empowerment, and socially responsive research
            across  scientific,  clinical,  and  community  settings.
            The Centre prioritises inclusive training, structured   The SAMRC Centre for Tuberculosis Research
            mentorship, gender transformation, and meaningful      is a key part of South Africa’s fight against the
            community engagement to strengthen both                ongoing TB epidemic.
            individual capability and institutional sustainability.



            80          SA M R C  A N N U A L R EP O R T 2 0 2 5 / 2 0 2 6
   77   78   79   80   81   82   83   84   85   86   87